Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc.（CAPR）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
capr · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$62.00
Consensus
$48.75
+85.0% upside
Low
$38.00
Median: $47.5 · Last Close: $26.35
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$48.75
85.0% upside
High Target
$62
135.3%
Low Target
$38
44.2%
Current Price
$26.35
as of today
Based on analyst price targets, the CAPR stock price prediction for the next 12 months ranges from $38 to $62. The consensus CAPR price forecast of $48.75 implies 85.0% upside from the current price of $26.35.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $25.33 | ↓ 3.90% |
1-day model range: $25.13–$25.52. Peak: $25.52 (-3.90%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CAPR · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-13 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-13 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-15 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-12-10 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-12-08 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-12-04 | Maxim Group | Maintains | Buy→Buy |
| 2025-12-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Capricor Therapeutics, Inc. (CAPR) stock. Of the recent 49 rating actions, 0 were upgrades and 0 were downgrades. 10 analysts currently cover CAPR.
分析师推荐趋势
CAPR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$117M
↓ 52.2% YoY
Revenue Next Year
$105M
↓ 10.9% YoY
EPS This Year
$-0.59
EPS Next Year
$-0.69
↑ 17.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast CAPR EPS of $-0.59 for the current fiscal year, based on estimates from 7 analysts. The CAPR revenue forecast is $117M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CAPR 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CAPR 的共识目标价为 $48.75（+85.0% 上行空间），分析师共识为 Buy。
CAPR 的短期预测（明日）为 $25.33（-3.90%）。
Capricor Therapeutics, Inc. 在 NASDAQ 上市，代码 CAPR。CAPR 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CAPR 预测 · 8 个问题根据 10 位华尔街分析师，CAPR 的 12 个月平均目标价为 $48.75，最高 $62.00、最低 $38.00。若有图表，中位目标价可在上方查看。相对当前价 $26.35，隐含约 +85.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.